Southwest Oncology Network  
Home
About Us
Membership Benefits
Member News
In The News
SWON Partner Network
Oncology Supply
Oncology Resources
Contact Us
Group Price Matching
Shared Administrative Fees
Competitive Pricing
Rebates on Generic Products
Rebates on Pharmacy PreFill Products
Free Access to the Oncology Manager Briefcase
Listserv
Many more...
 
  Oncology Learning Centers' Calendar of Events
Posted On 07-Jan-2010

To view Oncology Learning Center\'s calendar of Oncology industry events, click the following link:  http://www.oncologylearningcenter.com/calendar.php


  Newsletter_December 09
Posted On 16-Dec-2009

To view the SWON December 2009 Newsletter, click here.


  Newsletter_October 09
Posted On 16-Oct-2009

To view the October 09 SWON Newsletter, click here.


  Newsletter_August 09
Posted On 17-Aug-2009

To view the August 09 SWON Newsletter, click here.


  Roche's Avastin gets U.S. nod for kidney cancer
Posted On 03-Aug-2009

 ZURICH, Aug 3 (Reuters) - Roche Holding AG's (ROG.VX) cancer drug Avastin has won approval from the U.S. Food and Drug Administration (FDA) for the treatment of the most common type of kidney cancer, the Swiss drugmaker said on Monday.


  Newsletter_July 09
Posted On 15-Jul-2009

To view the July 09 SWON Newsletter, click here.


  Quarter 3 2009 Drug Pricing Files Available Now
Posted On 30-Jun-2009

The July 2009 ASP pricing files are now available on the Centers for Medicare & Medicaid Services (CMS) website. CMS says that for the most part average drug prices in the market remain stable with an average increase of less than one percent for the top part B drugs. According to CMS prices changed 2% or less for 30 out of the top 50 drugs (based on volume). The prices for 33 of the top 50 drugs increased, while 2 remained the same. www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/01a1_2009aspfiles.asp


  Newsletter_June 09
Posted On 15-Jun-2009

To view the June 09 Newsletter, click here


  SWON May Newsletter
Posted On 18-May-2009

The SWON May Newsletter was published on May 15, 2009.  Click here for a copy.


  FDA Announces Leucovorin Shortage is Resolved
Posted On 12-May-2009

The FDA reports that the Leucovorin shortage has been resolved and that both Bedford Laboratories and Teva Pharmaceuticals have supplies available. The following information is available on the FDA website at: www.fda.gov/cder/drug/shortages/default.htm#Leucovorin


  Bayer Quarantine of Leukine: Leukine Recall
Posted On 23-Mar-2009

In a letter to practices on March 23, 2009:

 
Bayer HealthCare Pharmaceuticals, in consultation with the U.S. Food and Drug Administration (FDA), has decided to recall Commercial Lot B13958 of Leukine® (sargramostim) liquid 500 mcg vials. We are taking this action because Lot B13958 did not meet one of the established parameters of our ongoing product stability monitoring. Bayer also alerted the FDA that, as a result of its investigation into this situation, we plan to remove Commercial Lot B12964 from the market. Even though this lot was initially within established parameters for stability monitoring, we have observed a high degree of variability in further stability test results.
 
Click here for the complete letter.

  SWON January 09 Newsletter
Posted On 30-Jan-2009

The SWON January Newsletter was published on January 30, 2009.  Click here for a copy.


  SWON December 08 Newsletter
Posted On 09-Jan-2009

The SWON December Newsletter was published on December 19, 2008.  Click here for a copy.


  CMS Publishes Q1 2009 Reimbursement
Posted On 17-Dec-2008

The Centers for Medicare & Medicaid Services (CMS) has made available the Medicare Part B Drug and Biological Average Sales Price (ASP) Payment Amounts for Q1 2009 on the CMS website at: http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/01a1_2009aspfiles.asp#TopOfPage

The files are located in the \\\\"Downloads\\\\" section of this web page.


  Pain Management Fact Sheet-LLS
Posted On 27-Oct-2008

The Leukemia & Lymphoma Society has recently updated their pain management fact sheet. It's available at http://www.leukemia-lymphoma.org/attachments/National/br_1222354169.pdf


  CMS Recovery Audit Contractors (RAC)
Posted On 14-Oct-2008

The Centers for Medicare & Medicaid Services (CMS) Recovery Audit Contractors (RAC) program to address fraud concerns has been announced. The program will initially start with four contractors in selected states and will include all the states nationwide no later than 2010. The RAC program mission is to detect and correct past improper payments and to implement actions to prevent further improper payments. Claims with unusually high volume or high dollars will be examined and visits to the providers may also be warranted.

 
The four RACS listed below begin their work on a contingency fee basis on October 1, 2008:
  1. Diversified Collection Services, Inc. of Livermore, California, in Region A
    Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, and New York
  2. CGI Technologies and Solutions, Inc. of Fairfax, Virginia, in Region B
    Michigan, Indiana, and Minnesota
  3. Connolly Consulting Associates, Inc. of Wilton, Connecticut, in Region C
    South Carolina, Florida, Colorado, and New Mexico
  4. HealthDataInsights, Inc. of Las Vegas, Nevada, in Region D
    Montana, Wyoming, North Dakota, South Dakota, Utah, and Arizona
 
California, Texas, Nevada, and Oklahoma will be added on March 1, 2009, and the other states will be added on August 1, 2009, or later.
 
CMS will roll out the program with an emphasis on provider education and is working towards resolving the appeals process which was an issue from the demonstration program last year.
 
RACs must document a targeted area they would like to review and CMS will decide if RACs can conduct the review.
 
CMS will limit the number of medical record requests RACs make of providers in one month, and will also limit the look-back period to October 1, 2007. Additionally, each RAC is required to hire a physician medical director and coder before they begin claims analysis.
 
In order to address some of the concerns of the provider community, CMS made numerous alterations to the initial RAC demonstration project. One of the changes includes the creation of a CMS review board, which will be in place to streamline the appeal process.
 
Review of evaluation and management services will be included in the RAC program. Documentation verifying the levels of service selected by coders will be checked.
 
The RACs will have a claim status Web site on which they will post all medical requests. This will allow the opportunity for everyone to be aware of the issues and vulnerabilities.
 
The GAO will report back on the RAC rollout.

  October SWON 08 Information Exchange Published
Posted On 08-Oct-2008

The October SWON Information Exchange was published on October 2, 2008.  Click here for a copy.


  APP Cytarabine
Posted On 22-Jul-2008

Please Click Here for important information from APP Pharmaceuticals regarding the use of Cytarabine.
https://www.oncologysupply.com/content/oncsupply/cms/files/Cytarabine_-_24778.pdf